Skip to Main Content

1,083

Views

0

CrossRef citations to date

0

Altmetric

Pneumococcal

A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR)

Alvino Maestria MRL, Merck & Co., Inc., Rahway, NJ, USACorrespondence[email protected]
View further author information

,

Su Eun Parkb Department of Pediatrics, Pusan National University Children’s Hospital, Yangsan, Republic of KoreaView further author information

,

Fiona Fernandesa MRL, Merck & Co., Inc., Rahway, NJ, USAView further author information

,

Zhongyi “Lucy” Lia MRL, Merck & Co., Inc., Rahway, NJ, USAView further author information

,

Yae-Jean Kimc Department of Pediatrics, Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, Republic of KoreaView further author information

,

Yun-Kyung Kimd Department of Pediatrics, Korea University College of Medicine, Seoul, Republic of KoreaView further author information

,

Jin Leee Department of Pediatrics, Incheon St. Mary’s Hospital, Incheon, Republic of KoreaView further author information

,

Ji Young Parkf Department of Pediatrics, Chung-Ang University Hospital, Seoul, Republic of KoreaView further author information

,

Dong Hyun Kimg Department of Pediatrics, Inha University Hospital, Incheon, Republic of KoreaView further author information

,

GyongSeon Yangh Global Medical Scientific Affairs, MSD Korea, Seoul, Republic of KoreaView further author information

,

Hyunjung Limi Global Clinical Trial Operations, MSD Korea, Seoul, Republic of KoreaView further author information

,

Jin Oh Kimh Global Medical Scientific Affairs, MSD Korea, Seoul, Republic of KoreaView further author information

,

Robert Lupinaccia MRL, Merck & Co., Inc., Rahway, NJ, USAView further author information

,

Tina M. Sterlinga MRL, Merck & Co., Inc., Rahway, NJ, USAView further author information

,

Marissa Wilcka MRL, Merck & Co., Inc., Rahway, NJ, USA

https://orcid.org/0000-0002-6890-1118 View further author information

,

Alejandra Esteves-Jaramilloa MRL, Merck & Co., Inc., Rahway, NJ, USAView further author information

&

Natalie Banniettisa MRL, Merck & Co., Inc., Rahway, NJ, USAView further author information